Non-invasive liver fibrosis test for predicting cirrhosis complicated with portal hypertension

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000034735

Enrollment

Unknown

Registered

2020-07-17

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis

Interventions

Patients with simple esophageal and gastric varices:Nil

Patients with esophageal and gastric varices bleeding:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with cirrhosis (including hepatitis B cirrhosis, hepatitis C cirrhosis, alcoholic cirrhosis and cirrhosis caused by other reasons), both male and female, aged 18-75 years.

Exclusion criteria

Exclusion criteria: Exclusion of liver cancer, and patients combined with other serious complications and complications.

Design outcomes

Primary

Measure	Time frame
PLT;Spleen length;GP73;APRI;FIB-4;ALB;Child-Pugh Score;	—

Countries

China

Contacts

Public ContactShasha Li

The Second People's Hospital of Fuyang City

lishasha20080808@163.com+86 13855886048

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026